Literature DB >> 15539674

Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis.

Anthony D Harries1, Edwin Libamba, Erik J Schouten, Andrina Mwansambo, Felix M Salaniponi, Rex Mpazanje.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15539674      PMCID： PMC527699          DOI： 10.1136/bmj.329.7475.1163

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.

Authors:  D K Warndorff; M Yates; B Ngwira; S Chagaluka; P A Jenkins; F Drobniewski; J M Pönnighaus; J R Glynn; P E Fine
Journal:  Int J Tuberc Lung Dis       Date:  2000-08       Impact factor: 2.373

Review 2.  Antiretroviral therapy in Africa.

Authors:  Warren Stevens; Steve Kaye; Tumani Corrah
Journal:  BMJ       Date:  2004-01-31

3.  Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Authors:  A Mocroft; B Ledergerber; C Katlama; O Kirk; P Reiss; A d'Arminio Monforte; B Knysz; M Dietrich; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

4.  Doubts about DOT: antiretroviral therapy for resource-poor countries.

Authors:  Cheryl A Liechty; David R Bangsberg
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

5.  Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision.

Authors:  A Banerjee; A D Harries; N Mphasa; T E Nyirenda; J Veen; T Ringdal; J Van Gorkom; F M Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2000-04       Impact factor: 2.373

6.  Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress.

Authors:  Jennifer Adelson Mitty; Valerie E Stone; Michael Sands; Grace Macalino; Timothy Flanigan
Journal:  Clin Infect Dis       Date:  2002-02-27       Impact factor: 9.079

7.  Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.

Authors:  A J Manders; A Banerjee; H W van den Borne; A D Harries; G J Kok; F M Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2001-09       Impact factor: 2.373

8.  Preventing antiretroviral anarchy in sub-Saharan Africa.

Authors:  A D Harries; D S Nyangulu; N J Hargreaves; O Kaluwa; F M Salaniponi
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

9.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

Review 10.  Global health improvement and WHO: shaping the future.

Authors:  Lee Jong-wook
Journal:  Lancet       Date:  2003-12-20       Impact factor: 79.321
  10 in total
  19 in total

1.  Highly active antiretroviral therapy.

Authors:  Peter Mugyenyi
Journal:  BMJ       Date:  2004-11-13

Review 2.  Extending HIV care in resource-limited settings.

Authors:  Kara Wools-Kaloustian; Sylvester Kimaiyo
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

3.  Antiretroviral therapy (ART) rationing and access mechanisms and their impact on youth ART utilization in Malawi.

Authors:  Jimmy-Gama Dixon; Sarah Gibson; Barbara McPake; Ken Maleta
Journal:  Malawi Med J       Date:  2011-06       Impact factor: 0.875

4.  Characteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: findings from an integrated HIV/TB clinic.

Authors:  C Feldacker; H Tweya; O Keiser; R Weigel; M Kalulu; L Fenner; M Egger; E Manda; J B Mwafilaso; C Kamba; S Phiri
Journal:  Trop Med Int Health       Date:  2012-07-19       Impact factor: 2.622

5.  The development of health policy in Malawi: the influence of context, evidence and links in the creation of a national policy for cotrimoxazole prophylaxis.

Authors:  Eleanor Hutchinson
Journal:  Malawi Med J       Date:  2011-12       Impact factor: 0.875

6.  Epidemiology of Respiratory Disease in Malawi.

Authors:  Stephen Gordon; Stephen Graham
Journal:  Malawi Med J       Date:  2006-09       Impact factor: 0.875

7.  Timing of antiretroviral therapy and effects on tuberculosis treatment outcomes in HIV-co-infected patients in Malawi.

Authors:  H S Kanyerere; J Mpunga; H Tweya; M Edginton; A D Harries; S G Hinderaker; F Chimbwandira; A Gonani; K Mbendera
Journal:  Public Health Action       Date:  2012-10-30

8.  How operational research influenced the scale up of antiretroviral therapy in Malawi.

Authors:  Anthony D Harries; Simon D Makombe; Erik J Schouten; Andreas Jahn; Edwin Libamba; Kelita Kamoto; Frank Chimbwandira
Journal:  Health Care Manag Sci       Date:  2011-11-24

9.  Health systems' responses to the roll-out of antiretroviral therapy (ART) in India: a comparison of two HIV high-prevalence settings.

Authors:  Abhay Kudale; Solomon Salve; Sheela Rangan; Karina Kielmann
Journal:  AIDS Care       Date:  2010

10.  Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi.

Authors:  Simon D Makombe; Mindy Hochgesang; Andreas Jahn; Hannock Tweya; Bethany Hedt; Stuart Chuka; Joseph Kwong-Leung Yu; John Aberle-Grasse; Olesi Pasulani; Christopher Bailey; Kelita Kamoto; Erik J Schouten; Anthony D Harries
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.